| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-05 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.13 | 0.001 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.002 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.12 | 0.003 |